title: Expansion of a BCR-ABL clone in a JAK2 V617F myeloproliferative neoplasm treated by ruxolitinib.
authors.affiliation: CHU Brest, Laboratoire d'Hématologie, Brest, France.
authors.forename: Damien
authors.initials: D
authors.lastname: Luque Paz
authors.affiliation: CHU Brest, Service d'Hématologie, Institut de Cancéro-Hématologie, Brest, France.
authors.forename: Jean-Christophe
authors.initials: JC
authors.lastname: Ianotto
authors.affiliation: CHU Brest, Laboratoire d'Hématologie, Brest, France.|INSERM U1078, Brest, France.
authors.forename: Aurélie
authors.initials: A
authors.lastname: Chauveau
authors.affiliation: CHU Brest, Service d'Anatomie et Cytologie Pathologiques, Brest, France.
authors.forename: Briac
authors.initials: B
authors.lastname: Guibourg
authors.affiliation: CHU Brest, Laboratoire d'Hématologie, Brest, France.
authors.forename: Lydie
authors.initials: L
authors.lastname: Lecucq
authors.affiliation: CHU Brest, Laboratoire d'Hématologie, Brest, France.|INSERM U1078, Brest, France.
authors.forename: Eric
authors.initials: E
authors.lastname: Lippert
authors.affiliation: CHU Angers, Laboratoire d'Hématologie, 4 Rue Larrey, 49933, Angers Cedex 9, France. valerie.ugo@chu-angers.fr.
authors.forename: Valérie
authors.initials: V
authors.lastname: Ugo
mesh_terms: D005260:Female; D016044:Fusion Proteins, bcr-abl / Q000235:genetics*; D006801:Humans; D053614:Janus Kinase 2 / Q000037:antagonists & inhibitors* / Q000235:genetics*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics*; D008875:Middle Aged; D009196:Myeloproliferative Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics; D009570:Nitriles; D011720:Pyrazoles / Q000494:pharmacology / Q000627:therapeutic use*; D011743:Pyrimidines; D016896:Treatment Outcome
chemical_list: D009570:Nitriles; D011720:Pyrazoles; D011743:Pyrimidines; C540383:ruxolitinib; D016044:Fusion Proteins, bcr-abl; C507924:JAK2 protein, human; D053614:Janus Kinase 2